NCT04848077 STEPWISE Parkinson: A Smartphone Based Exercise Solution for Patients With Parkinson's Disease
| NCT ID | NCT04848077 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Radboud University Medical Center |
| Condition | Movement Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 452 participants |
| Start Date | 2021-05-18 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 452 participants in total. It began in 2021-05-18 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to investigate whether a smartphone app can increase physical activity in patients with Parkinson's Disease in daily life for a long period of time (12 months).
Eligibility Criteria
Inclusion Criteria: * idiopathic PD * Hoehn and Yahr 1-3 * able to understand the Dutch language * able to walk independently * equal to or less than 120 minutes of sports/outdoor activities per day (question 5-28 LASA Physical Activity Questionnaire (LAPAQ)) * less than 7,000 steps/day during 1-month baseline (week -4 until 0) Exclusion Criteria: * weekly falls in the previous 3 months * medical conditions that hamper mobility other than PD * living in a nursing home * cognitive impairments that hamper use of the motivational app (subjective evaluation by the assessor) * not in the possession of a suitable smartphone (Iphone 5S or newer with iOS 10 or higher or Android 4.1 or newer)
Contact & Investigator
Bastiaan Bloem, Prof. Dr.
PRINCIPAL INVESTIGATOR
Radboudumc Department of Neurology
Frequently Asked Questions
Who can join the NCT04848077 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Movement Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04848077 currently recruiting?
Yes, NCT04848077 is actively recruiting participants. Contact the research team at sabine.schootemeijer@radboudumc.nl for enrollment information.
Where is the NCT04848077 trial being conducted?
This trial is being conducted at Nijmegen, Netherlands.
Who is sponsoring the NCT04848077 clinical trial?
NCT04848077 is sponsored by Radboud University Medical Center. The principal investigator is Bastiaan Bloem, Prof. Dr. at Radboudumc Department of Neurology. The trial plans to enroll 452 participants.